Skip to main content
VKTX
NASDAQ Life Sciences

Viking Therapeutics Launches $400M Dual Offering to Fund Obesity Pipeline

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$41.43
Mkt Cap
$4.859B
52W Low
$24.78
52W High
$43.15
52W Position info
67% above low
Off High info
4.0% below high
Rel. Volume info
4.7× avg
Market data snapshot near publication time

VKTX sits 67% above its 52-week low of $24.78 on elevated volume (4.7× avg).

Summary

Viking Therapeutics is raising $400M through concurrent offerings of $200M in common stock and $200M in convertible senior notes due 2032, each with a 30-day underwriters' option for up to $30M more. The proceeds will fund late-stage development of VK2735 and VK3019, plus R&D and G&A. This follows positive Phase 2 maintenance data for VK2735 reported yesterday and the recent initiation of the Phase 3 Vanquish program. The equity component is dilutive and the convertible notes add potential future dilution, creating near-term overhang on the stock. Pricing terms—interest rate, conversion premium, and discount—will determine the actual dilution and set the trading range. The company had $502M in cash as of Q2 2026, so this raise extends runway significantly for the obesity pipeline.

At the time of this announcement, VKTX was trading at $41.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.9B. The 52-week trading range was $24.78 to $43.15. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

VKTX - Latest Insights

VKTX
Oct 29, 2026, 10:43 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $27.18
Real-time Price: $28.74 info
Change: +$1.56 (+6%) info
Market Cap: $3.665B info
VKTX
Oct 28, 2026, 5:40 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $24.70
Real-time Price: $28.74 info
Change: +$4.04 (+16%) info
Market Cap: $3.665B info
VKTX
Oct 28, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.38
Real-time Price: $28.74 info
Change: +$4.36 (+18%) info
Market Cap: $3.665B info
VKTX
Oct 28, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $25.41
Real-time Price: $28.74 info
Change: +$3.33 (+13%) info
Market Cap: $3.665B info
VKTX
Sep 28, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $33.28
Real-time Price: $28.74 info
Change: -$4.54 (-14%) info
Market Cap: $3.665B info